Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 5/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4936048 | 1.00 | AGTR1 (0.43) | AGTR1AGTR2CTSKBCHEACHE | |
| SCHEMBL4933996 | 0.94 | AGTR1 (0.41) | AGTR1AGTR2CTSKBCHEACHE | |
| SCHEMBL4933987 | 0.94 | AGTR1 (0.41) | AGTR1AGTR2CTSKBCHEACHE | |
| SCHEMBL4928025 | 0.92 | CTSK (0.43) | CTSKBCHEACHECTSSTP53 | |
| SCHEMBL4935818 | 0.90 | AGTR1 (0.45) | AGTR1AGTR2CTSKCTSS | |
| SCHEMBL4935805 | 0.90 | AGTR1 (0.45) | AGTR1AGTR2CTSKCTSS | |
| SCHEMBL4930469 | 0.90 | TP53 (0.49) | CTSKTP53 | |
| SCHEMBL4930481 | 0.90 | TP53 (0.49) | CTSKTP53 | |
| SCHEMBL4934662 | 0.89 | TP53 (0.49) | TP53 | |
| SCHEMBL4934667 | 0.89 | TP53 (0.49) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080132539-A1 | Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative | KUREHA CORPORATION (JP) | 2008-06-05 | — | — | US | disclosed |
| EP-1707560-A1 | HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE | Kureha Corporation (JP) | 2006-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132539-A1 | Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative | HDAC5, HDAC1, HDAC9 | AGTR1 377/4885AGTR2 327/4885CTSK 322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.